{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:35:55Z","timestamp":1791653755678,"version":"4.3.4"},"reference-count":29,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical Countermeasure Systems\u2014Joint Vaccine Acquisition Program","award":["1885296"],"award-info":[{"award-number":["1885296"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The purpose of this study was to evaluate the effects of the route of administration on the immunogenicity and efficacy of a combined western, eastern, and Venezuelan equine encephalitis (WEVEE) virus-like replicon particle (VRP) vaccine in cynomolgus macaques. The vaccine consisted of equal amounts of WEEV, EEEV, and VEEV VRPs. Thirty-three animals were randomly assigned to five treatment or control groups. Animals were vaccinated with two doses of WEVEE VRPs or the control 28 days apart. Blood was collected 28 days following primary vaccination and 21 days following boost vaccination for analysis of the immune response to the WEVEE VRP vaccine. NHPs were challenged by aerosol 28 or 29 days following second vaccination with WEEV CBA87. Vaccination with two doses of WEVEE VRP was immunogenic and resulted in neutralizing antibody responses specific for VEEV, EEEV and WEEV. None of the vaccinated animals met euthanasia criteria following aerosol exposure to WEEV CBA87. However, one NHP control (total of 11 controls) met euthanasia criteria after infection with WEEV CBA87. Statistically significant differences in median fever hours were noted in control NHPs compared to vaccinated NHPs, providing a quantitative measure of infection and efficacy of the vaccine against a WEEV challenge. Alterations in lymphocytes, monocytes, and neutrophils were observed. Lymphopenia was observed in control NHPs.<\/jats:p>","DOI":"10.3390\/v14071502","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:06:21Z","timestamp":1657497981000},"page":"1502","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Efficacy of Western, Eastern, and Venezuelan Equine Encephalitis (WEVEE) Virus-Replicon Particle (VRP) Vaccine against WEEV in a Non-Human Primate Animal Model"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8734-8912","authenticated-orcid":false,"given":"Crystal W.","family":"Burke","sequence":"first","affiliation":[{"name":"Virology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5838-9026","authenticated-orcid":false,"given":"Rebecca A.","family":"Erwin-Cohen","sequence":"additional","affiliation":[{"name":"Virology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee I.","family":"Goodson","sequence":"additional","affiliation":[{"name":"Virology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Wilhelmsen","sequence":"additional","affiliation":[{"name":"Pathology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Edmundson","sequence":"additional","affiliation":[{"name":"Pathology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4359-9984","authenticated-orcid":false,"given":"Charles E.","family":"White","sequence":"additional","affiliation":[{"name":"Veterinary Medicine Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"Glass","sequence":"additional","affiliation":[{"name":"Virology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD 21702, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"key":"ref_1","unstructured":"The Center for Food Security & Public Health (2022, January 28). Eastern, Western and Venezuelan Equine Encephalomyelitis. Available online: https:\/\/www.cfsph.iastate.edu\/Factsheets\/pdfs\/easter_wester_venezuelan_equine_encephalomyelitis.pdf."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1126\/science.158.3806.1283","article-title":"Arbovirus infections of laboratory workers. Extent of problem emphasizes the need for more effective measures to reduce hazards","volume":"158","author":"Hanson","year":"1967","journal-title":"Science"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1086\/444397","article-title":"Aerosol exposure to western equine encephalitis virus causes fever and encephalitis in cynomolgus macaques","volume":"192","author":"Reed","year":"2005","journal-title":"J Infect. Dis."},{"key":"ref_4","unstructured":"Bozue, J., Cote, C.K., and Glass, P.J. (2018). Alphavirus Encephalitides. Medical Aspects of Biological Warfare, Borden Institute."},{"key":"ref_5","unstructured":"Department of Health and Humans Service, Centers for Disease Prevention and Control (2022, January 28). Bioterrorism Agents\/Diseases, Available online: https:\/\/emergency.cdc.gov\/agent\/agentlist-category.asp."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1099\/vir.0.81815-0","article-title":"Infectivity variation and genetic diversity among strains of Western equine encephalitis virus","volume":"87","author":"Nagata","year":"2006","journal-title":"J. Gen. Virol."},{"key":"ref_7","unstructured":"U.S. Army, Medical Materiel Development Agency (2022, January 28). Special Immunizations Program. Available online: https:\/\/www.usammda.army.mil\/index.cfm\/fhp\/immunizations_program."},{"key":"ref_8","unstructured":"Bozue, J., Cote, C.K., and Glass, P.J. (2018). Medical Countermeasures. Medical Aspects of Biological Warfare, Borden Institute."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"12077","DOI":"10.1128\/JVI.01406-14","article-title":"Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses","volume":"88","author":"Reed","year":"2014","journal-title":"J. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/viro.1997.8878","article-title":"Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: Expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo","volume":"239","author":"Pushko","year":"1997","journal-title":"Virology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.addr.2005.01.011","article-title":"Viral vectors for use in the development of biodefense vaccines","volume":"57","author":"Lee","year":"2005","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"eaav3113","DOI":"10.1126\/scitranslmed.aav3113","article-title":"A virus-like particle vaccine prevents equine encephalitis virus infection in nonhuman primates","volume":"11","author":"Ko","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1293\/tox.25.63","article-title":"Histopathology of incidental findings in cynomolgus monkeys (Macaca fascicularis) used in toxicity studies","volume":"25","author":"Sato","year":"2012","journal-title":"J. Toxicol. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/0192623314537723","article-title":"Microscopic background changes in brains of cynomolgus monkeys","volume":"43","author":"Butt","year":"2015","journal-title":"Toxicol. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/imm.13152","article-title":"Skin barrier immunity and ageing","volume":"160","author":"Chambers","year":"2020","journal-title":"Immunology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1007\/s11095-016-1979-0","article-title":"Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?","volume":"33","author":"Bobbala","year":"2016","journal-title":"Pharm. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/00365548709117195","article-title":"Intradermal, subcutaneous or intramuscular administration of hepatitis B vaccine: Side effects and antibody response","volume":"19","author":"Wahl","year":"1987","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/0264-410X(96)00044-8","article-title":"Immunogenicity and safety of a new inactivated hepatitis A vaccine: A clinical trial with comparison of administration route","volume":"14","author":"Fisch","year":"1996","journal-title":"Vaccine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.vaccine.2005.11.057","article-title":"Reactogenicity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults","volume":"24","author":"Cook","year":"2006","journal-title":"Vaccine"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Gillet, Y., Habermehl, P., Thomas, S., Eymin, C., and Fiquet, A. (2009). Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro) and a varicella vaccine (VARIVAX) by intramuscular or subcutaneous routes at separate injection sites: A randomised clinical trial. BMC Med., 7.","DOI":"10.1186\/1741-7015-7-16"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.vaccine.2015.12.057","article-title":"Comparable immune responsiveness but increased reactogenicity after subcutaneous versus intramuscular administration of tick borne encephalitis (TBE) vaccine","volume":"34","author":"Hopf","year":"2016","journal-title":"Vaccine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1016\/j.vaccine.2009.02.090","article-title":"Immune interference after sequential alphavirus vaccine vaccinations","volume":"27","author":"Pittman","year":"2009","journal-title":"Vaccine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/514240","article-title":"Immunologic interference from sequential administration of live attenuated alphavirus vaccines","volume":"177","author":"McClain","year":"1998","journal-title":"J. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"598847","DOI":"10.3389\/fimmu.2020.598847","article-title":"A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge","volume":"11","author":"Henning","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_25","unstructured":"Department of Health and Human Service, U.S. Food and Drug Administration (2022, April 07). Product Development Under the Animal Rule: Guidance for Industry, Available online: https:\/\/www.fda.gov\/media\/88625\/download."},{"key":"ref_26","first-page":"164","article-title":"Infectious equine encephalomyelitis in the United States in 1951","volume":"121","author":"Simms","year":"1952","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_27","first-page":"212","article-title":"Human encephalitis in Saskatchewan caused by the virus of western equine encephalomyelitis","volume":"43","author":"Fulton","year":"1952","journal-title":"Can. J. Public Health"},{"key":"ref_28","first-page":"455","article-title":"Human encephalitis due to the Western equine encephalomyelitis virus","volume":"41","author":"Sulkin","year":"1946","journal-title":"Tex. State J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3201\/eid1705.101068","article-title":"Fatal Human Case of Western Equine Encephalitis, Uruguay","volume":"17","author":"Delfraro","year":"2011","journal-title":"Emerg. Infect. Dis."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/7\/1502\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:47:02Z","timestamp":1760140022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/7\/1502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["v14071502"],"URL":"https:\/\/doi.org\/10.3390\/v14071502","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]}}}